NCT03772288 - A Study of TAK-659 in Combination With NKTR-214 in Participants With Advanced Non-Hodgkin Lymphoma (NHL) | Biotech Hunter

Timeline

Start Date

April 3, 2019

Primary Completion Date

November 10, 2021

Study Completion Date

November 17, 2021

Conditions

Lymphoma, Non-Hodgkin

Interventions

DRUG

TAK-659

Tablets.

DRUG

NKTR-214

Intravenous infusion.

Trial Locations (6)

New York University Langone Medical Center, New York

University of Alabama at Birmingham, Birmingham

Henry Ford Hospital, Detroit

Alberta Health Services, Calgary

Jewish General Hospital, Montreal

Centre Hospitalier Universitaire de Sherbrooke (CIUSSS de lEstrie - CHUS), Sherbrooke